Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial Fibrillation

Heart Lung and Circulation

Volumn 25, Issue 3, 2016, Pages 243-249

  Wang, Tom Kai Ming ^a,b   Sathananthan, Janarthanan ^a,b   Marshall, Mark ^b   Kerr, Andrew ^b   Hood, Chris ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Atrial fibrillation; Chronic kidney failure; Dialysis; Stroke; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; ADVERSE OUTCOME; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHA2DS2 VAS SCORE; CHADS2 SCORE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; EMBOLISM; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HAS BLED SCORE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT RESPONSE; AGED; CHEMICALLY INDUCED; HEMODIALYSIS; RETROSPECTIVE STUDY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; EMBOLISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; WARFARIN;

EID: 84958119082     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.08.012     Document Type: Article

References (28)

1. Camm A.J., Kirchhof P., Lip G.Y., Schotten U., Savelieva I., Ernst S., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery.
2. Genovesi S., Pogliani D., Faini A., Valsecchi M.G., Riva A., Stefani F., et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005, 46:897-902.
3. Winkelmayer W.C., Patrick A.R., Liu J., Brookhart M.A., Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011, 22:349-357.
4. Goldstein B.A., Arce C.M., Hlatky M.A., Turakhia M., Setoguchi S., Winkelmayer W.C. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 2012, 126:2293-2301.
5. Zimmerman D., Sood M.M., Rigatto C., Holden R.M., Hiremath S., Clase C.M. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012, 27:3816-3822.
6. Wann L.S., Curtis A.B., Ellenbogen K.A., Estes N.A., Ezekowitz M.D., Jackman W.M., et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2013, 127:1916-1926. American College of Cardiology Foundation; American Heart Association; European Society of Cardiology, Heart Rhythm Society.
7. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857-867.
8. Abbott K.C., Trespalacios F.C., Taylor A.J., Agodoa L.Y. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 2003, 4:1.
9. To A.C., Yehia M., Collins J.F. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?. Nephrology (Carlton) 2007, 12:441-447.
10. Chan K.E., Lazarus J.M., Thadhani R., Hakim R.M. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009, 20:2223-2233.
11. Wizemann V., Tong L., Satayathum S., Disney A., Akiba T., Fissell R.B., et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010, 77:1098-1106.
12. Winkelmayer W.C., Liu J., Setoguchi S., Choudhry N.K. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011, 6:2662-2668.
13. Wakasugi M., Kazama J.J., Tokumoto A., Suzuki K., Kageyama S., Ohya K., et al. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study. Clin Exp Nephrol. 2014, 18:662-669.
14. Genovesi S., Rossi E., Pogliani D., Gallieni M., Stella A., Badiali F., et al. The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation. J Nephrol 2014, 27:187-192.
15. Gage B.F., van Walraven C., Pearce L., Hart R.G., Koudstaal P.J., Boode B.S., et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004, 110:2287-2292.
16. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
17. Pisters R., Lane D.A., Nieuwlaat R., de Vos C.B., Crijns H.J., Lip G.Y. A Novel User-Friendly Score (Has-Bled) To Assess 1-Year Risk Of Major Bleeding In Patients With Atrial Fibrillation: The Euro Heart Survey. Chest 2010, 138:1093-1100.
18. Wiesholzer M., Harm F., Tomasec G., Barbieri G., Putz D., Balcke P. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001, 21:35-39.
19. Knoll F., Sturm G., Lamina C., Zitt E., Lins F., Freistätter O., et al. Coumarins and survival in incident dialysis patients. Nephrol Dial Transplant 2012, 27:332-337.
20. Sood M.M., Larkina M., Thumma J.R., Tentori F., Gillespie B.W., Fukuhara S., et al. Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS. Kidney Int 2013, 84:600-608.
21. Wetmore J.B., Ellerbeck E.F., Mahnken J.D., Phadnis M., Rigler S.K., Mukhopadhyay P., et al. Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol 2013, 23:112-118.
22. Shah M., Avgil Tsadok M., Jackevicius C.A., Essebag V., Eisenberg M.J., Rahme E., et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 2014, 129:1196-1203.
23. Chao T.F., Liu C.J., Wang K.L., Lin Y.J., Chang S.L., Lo L.W., et al. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm 2014, 11:1752-1759.
24. Lo D.S., Rabbat C.G., Clase C.M. Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management. Thromb Res 2005, 118:385-395.
25. Noris M., Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies?. Blood 1999, 94:2569-2574.
26. Himmelfarb J., Holbrook D., McMonagle E., Ault K. Increased reticulated platelets in dialysis patients. Kidney Int. 1997, 51:834-839.
27. Sohal A.S., Gangji A.S., Crowther M.A., Treleaven D. Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 2006, 118:417-422.
28. Vázquez E., Sánchez-Perales C., García-Cortes M.J., Borrego F., Lozano C., Guzmán M., et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?. Int J Cardiol 2003, 87:135-139.